Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (381-390 of 8,370) with videos related to

Pageof 837
Sort By:
Drugs|January 1, 1987
Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency. A study in general practice comprising 2772 patientsY Memin
Drugs|January 1, 1986
Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung diseaseJ A Pollard, R J Wallace, D R Nash, et al.
Drugs|January 1, 1986
Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapyK Lundgren, L Ingvarsson
Drugs|January 1, 1986
Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The NetherlandsB I Davies, F P Maesen
Drugs|January 1, 1986
Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United StatesD R Nash, R J Wallace, V A Steingrube, et al.
Drugs|January 1, 1986
Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitorsT Farmer, C Reading
Drugs|January 1, 1986
Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infectionsA Saito, K Yamaguchi, Y Shigeno, et al.
Drugs|March 19, 2021
Ravulizumab: A Review in Atypical Haemolytic Uraemic SyndromeYahiya Y Syed
Drugs|November 17, 2021
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type ANowell Solish, Jean Carruthers, Joely Kaufman, et al.
Drugs|March 25, 2021
Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Pageof 837

Showing results (381-390 of 8,370) with videos related to

Sort By:
Pageof 837
Drugs|January 1, 1987
Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency. A study in general practice comprising 2772 patientsY Memin
Drugs|January 1, 1986
Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung diseaseJ A Pollard, R J Wallace, D R Nash, et al.
Drugs|January 1, 1986
Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapyK Lundgren, L Ingvarsson
Drugs|January 1, 1986
Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The NetherlandsB I Davies, F P Maesen
Drugs|January 1, 1986
Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United StatesD R Nash, R J Wallace, V A Steingrube, et al.
Drugs|January 1, 1986
Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitorsT Farmer, C Reading
Drugs|January 1, 1986
Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infectionsA Saito, K Yamaguchi, Y Shigeno, et al.
Drugs|March 19, 2021
Ravulizumab: A Review in Atypical Haemolytic Uraemic SyndromeYahiya Y Syed
Drugs|November 17, 2021
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type ANowell Solish, Jean Carruthers, Joely Kaufman, et al.
Drugs|March 25, 2021
Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Pageof 837